Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC
Condition(s):Primary Biliary CholangitisLast Updated:August 7, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Primary Biliary CholangitisLast Updated:August 7, 2023Active, not recruiting
Condition(s):Primary Biliary CholangitisLast Updated:March 6, 2023Recruiting
Condition(s):Primary Biliary CholangitisLast Updated:October 10, 2023Withdrawn
Condition(s):Primary Biliary CholangitisLast Updated:August 2, 2022Completed
Condition(s):Primary Biliary CholangitisLast Updated:September 22, 2020Terminated
Condition(s):Primary Biliary CholangitisLast Updated:August 7, 2023Active, not recruiting
Condition(s):Primary Biliary Cholangitis; Liver StiffnessLast Updated:March 6, 2024Active, not recruiting
Condition(s):Primary Sclerosing Cholangitis; Primary Biliary Cirrhosis; Cholangiocarcinoma; Liver CancerLast Updated:March 15, 2024Recruiting
Condition(s):Autoimmune Liver Disease; Autoimmune Hepatitis; Primary Sclerosing Cholangitis; Primary Biliary CirrhosisLast Updated:March 13, 2024Not yet recruiting
Condition(s):Primary Sclerosing Cholangitis; Primary Biliary Cirrhosis; Gallstones; Liver DiseasesLast Updated:August 28, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.